ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Field Reimbursement Manager (Associate Director Level) at BridgeBio Pharma - ApplyBlast

Field Reimbursement Manager (Associate Director Level)

BridgeBio Pharma

9 days ago

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Field Reimbursement Manager serves as an individual contributor responsible for optimizing community access to the company's products and therapies by navigating complex reimbursement processes and healthcare regulations. This role involves developing strategic access plans, collaborating with healthcare providers and pharmacies, and managing community support programs to ensure patients can effectively utilize treatments. The position requires expertise in market access, data analysis, and stakeholder engagement to streamline patient access pathways.

Responsibilities

Develop and execute strategic plans for optimizing community access to products and therapies
Serve as an in-house expert on authorization processes and requirements to navigate complex access challenges
Collaborate with healthcare provider offices and pharmacies to address access issues and streamline patient pathways

Skills

About BridgeBio Pharma

bridgebio.com

Headquarters

Palo Alto, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers driven by clear genetic causes. The company advances programs from target discovery through clinical development, combining human genetics and translational science with rigorous clinical trials to create targeted therapeutics. BridgeBio builds a diversified portfolio of wholly owned and partnered programs across multiple modalities and uses a venture‑style operating model to accelerate and de‑risk development. Its mission is to translate genetic insights into precision medicines for patients with high unmet medical need.